Argus Pharmaceuticals Inc

Basic Information

3400 Research Forest Drive
The Woodlands, TX, 77381

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. FEASIBILITY OF PRECLINICAL SCALEUP OF LIPOSOMAL TNF

    Amount: $48,158.00

    IN THIS PHASE I EFFORT, WE WILL DEMONSTRATE THE ABILITY TO SCALE UP THE PRODUCTION OF A LEAD LIPOSOMAL FORMULATION CANDIDATE OF ACYLATED, LIPOPHILIC RHUTNF. WE WILL SUBJECT THE BACTERIAL RECOMBINANT P ...

    SBIR Phase I 1992 Department of Health and Human Services
  2. DEVELOPMENT OF OPTIMUM CONDITIONS FOR NIMC PRODUCTION

    Amount: $49,904.00

    MITOCHONDRIAL RESPIRATION INHIBITION IN TUMOR CELLS MAY OCCUR IN TWO MANNERS. ONE MECHANISM INVOLVES THE SYNTHESIS OF NITRIC OXIDE (NO) BY MACROPHAGES OR IFN-GAMMA MEDIATED INDUCTION OF NO SYNTHESIS I ...

    SBIR Phase I 1992 Department of Health and Human Services
  3. ISOLATION AND EXPRESSION OF CDNA CLONES FOR RIF

    Amount: $49,233.00

    CYTOTOXIC ACTIVATED MACROPHAGES SECRETE SOLUBLE FACTORS THAT HAVE A VARIETY OF EFFECTS ON TUMOR CELLS. INCLUDED IN THE TUMOR CELL RESPONSE ARE THE INHIBITION OF MITOCHONDRIAL RESPIRATION AND INHIBITIO ...

    SBIR Phase I 1991 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government